MedRx Co., Ltd (TYO:4586)

MedRx Statistics

Total Valuation

MedRx has a market cap or net worth of JPY 7.42 billion. The enterprise value is 5.67 billion.

Market Cap	7.42B
Enterprise Value	5.67B

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

MedRx has 59.37 million shares outstanding. The number of shares has increased by 23.62% in one year.

Current Share Class	59.37M
Shares Outstanding	59.37M
Shares Change (YoY)	+23.62%
Shares Change (QoQ)	+3.74%
Owned by Insiders (%)	3.15%
Owned by Institutions (%)	4.45%
Float	56.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	57.97
PB Ratio	3.63
P/TBV Ratio	3.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.05
EV / Sales	44.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.84

Financial Position

The company has a current ratio of 23.69

Current Ratio	23.69
Quick Ratio	22.94
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -44.46% and return on invested capital (ROIC) is -27.94%.

Return on Equity (ROE)	-44.46%
Return on Assets (ROA)	-26.57%
Return on Invested Capital (ROIC)	-27.94%
Return on Capital Employed (ROCE)	-45.29%
Weighted Average Cost of Capital (WACC)	8.65%
Revenue Per Employee	5.82M
Profits Per Employee	-42.59M
Employee Count	22
Asset Turnover	0.06
Inventory Turnover	0.15

Taxes

In the past 12 months, MedRx has paid 12.00 million in taxes.

Income Tax	12.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +50.60% in the last 52 weeks. The beta is 0.80, so MedRx's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	+50.60%
50-Day Moving Average	111.80
200-Day Moving Average	102.47
Relative Strength Index (RSI)	64.22
Average Volume (20 Days)	1,243,080

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedRx had revenue of JPY 128.00 million and -937.00 million in losses. Loss per share was -17.44.

Revenue	128.00M
Gross Profit	126.00M
Operating Income	-942.00M
Pretax Income	-925.00M
Net Income	-937.00M
EBITDA	-929.00M
EBIT	-942.00M
Loss Per Share	-17.44

Balance Sheet

The company has 1.75 billion in cash and n/a in debt, with a net cash position of 1.75 billion or 29.55 per share.

Cash & Cash Equivalents	1.75B
Total Debt	n/a
Net Cash	1.75B
Net Cash Per Share	29.55
Equity (Book Value)	2.05B
Book Value Per Share	34.45
Working Capital	1.75B

Cash Flow

In the last 12 months, operating cash flow was -888.00 million and capital expenditures -82.00 million, giving a free cash flow of -970.00 million.

Operating Cash Flow	-888.00M
Capital Expenditures	-82.00M
Free Cash Flow	-970.00M
FCF Per Share	-16.34

Margins

Gross Margin	98.44%
Operating Margin	-735.94%
Pretax Margin	-722.66%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MedRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.62%
Shareholder Yield	-23.62%
Earnings Yield	-12.63%
FCF Yield	-13.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MedRx has an Altman Z-Score of 25.21 and a Piotroski F-Score of 2.

Altman Z-Score	25.21
Piotroski F-Score	2